Labopharm gets Health Canada nod for tramadol
TORONTO, June 18 |
TORONTO, June 18 (Reuters) - Labopharm Inc. DDS.TO said on Monday it expects to begin selling its once-daily pain formula, tramadol, in Canada later this year after it received a Notice of Compliance from Health Canada.
The company said it is in talks to complete a licensing and distribution agreement for the drug, which will see the company retain the right to co-promote the product to certain specialties through its own sales force.
($1=$1.07 Canadian)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters